Nanosynth Group23 Aug 2021 11:45
nanosynth group is focused on the synthesis and application of nanoparticles. The group uses a patented process developed by Dr Cave at Nottingham Trent University. It has three subsidiaries; Pharm 2 Farm Ltd, nanosynth ltd and Cloudveil.
Pharm 2 Farm was founded by Dr Cave as a spin out from Nottingham Trent and was brought into the Group in 2020. Its initial focus was on producing products that maximise plant production whilst optimising nutrition use to minimise the carbon and environmental footprint of agriculture and horticulture. As well as developing advance plant nutrition products, Pharm 2 Farm has expanded into animal nutrition and disease control.
nanosynth was set up as a new subsidiary to focus on the non-agricultural applications, such as the anti-viral mask developed in 2020 to help prevent the spread of COVID-19 and other infectious viral and bacterial diseases. As well as opportunities in the healthcare and filtration markets, nanosynth will also look at human nutrition and advanced material.
Cloudveil is a security and risk management consultancy with the strategic aim of providing clients with seamless, in-depth protection in the most efficient and economical manner possible. Its incident management system IRIS enables users to rapidly and efficiently collect and analyse wide ranging data in bespoke formats such as threat risk assessments, audits and surveys.
All 3 subsidiaries are 100% owned by nanosynth group.
Sign In
Follow the stocks
